Published in Br J Clin Pharmacol on May 01, 1998
The role of therapeutic drug monitoring in treatment of HIV infection. Br J Clin Pharmacol (2001) 1.14
Therapeutic drug monitoring in human immunodeficiency virus/acquired immunodeficiency syndrome. Quo vadis? Arch Pathol Lab Med (2003) 0.77
Pharmacokinetic variability and strategy for therapeutic drug monitoring of saquinavir (SQV) in HIV-1 infected individuals. Br J Clin Pharmacol (1999) 0.77
Unsafe injections in the developing world and transmission of bloodborne pathogens: a review. Bull World Health Organ (1999) 4.80
Pattern and process in Amazon tree turnover, 1976-2001. Philos Trans R Soc Lond B Biol Sci (2004) 3.49
Concerted changes in tropical forest structure and dynamics: evidence from 50 South American long-term plots. Philos Trans R Soc Lond B Biol Sci (2004) 3.36
Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates. Bull World Health Organ (1999) 2.97
Oligonucleotide fingerprinting of isolates of Candida species other than C. albicans and of atypical Candida species from human immunodeficiency virus-positive and AIDS patients. J Clin Microbiol (1993) 2.87
Arterial dissections following cervical manipulation: the chiropractic experience. CMAJ (2001) 2.65
The Arabidopsis sex1 mutant is defective in the R1 protein, a general regulator of starch degradation in plants, and not in the chloroplast hexose transporter. Plant Cell (2001) 2.63
EULAR standardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing committees. Ann Rheum Dis (2004) 2.48
Comparison of the effects of dexamphetamine and 1-benzylpiperazine in former addicts. Eur J Clin Pharmacol (1973) 2.31
Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir. Br J Clin Pharmacol (1997) 2.26
The immunization data quality audit: verifying the quality and consistency of immunization monitoring systems. Bull World Health Organ (2005) 2.23
The pharmacokinetics of combination therapy with nelfinavir plus nevirapine. AIDS (1998) 2.16
AIDS across Europe, 1994-98: the EuroSIDA study. Lancet (2000) 2.13
Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection. Clin Pharmacokinet (1999) 2.10
An investigation of the pharmacokinetics of ethynylestradiol in women using radioimmunoassay. Contraception (1979) 1.97
The pharmacokinetics of lamivudine phosphorylation in peripheral blood mononuclear cells from patients infected with HIV-1. AIDS (1999) 1.78
High level ciprofloxacin resistance in Neisseria gonorrhoeae. Genitourin Med (1994) 1.76
A comparison of junior hospital doctors interpretation of acute radiographs using an X-ray box and a window. Ann R Coll Surg Engl (2001) 1.73
Effects of drugs on 2',3'-dideoxy-2',3'-didehydrothymidine phosphorylation in vitro. Antimicrob Agents Chemother (1997) 1.66
Saquinavir pharmacokinetics alone and in combination with ritonavir in HIV-infected patients. AIDS (1997) 1.65
The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects. Psychopharmacology (Berl) (2001) 1.64
Clinical pharmacokinetics of oral contraceptive steroids. Clin Pharmacokinet (1983) 1.64
Understanding and influencing starch biochemistry. Crit Rev Biochem Mol Biol (2000) 1.64
The metabolism of 17 alpha-ethinyloestradiol by human liver microsomes: formation of catechol and chemically reactive metabolites. Br J Clin Pharmacol (1987) 1.63
Insulin and glucose to reduce catabolic response to injury in burned patients. Lancet (1971) 1.62
Protease inhibitors in patients with HIV disease. Clinically important pharmacokinetic considerations. Clin Pharmacokinet (1997) 1.61
Assessing limiting factors to the acceptance of antiretroviral therapy in a large cohort of injecting drug users. HIV Med (2003) 1.61
Frequency and clinical significance of failure to visualize the conus artery during coronary arteriography. Circulation (1981) 1.58
Excellent clinical outcomes from a national donation-after-determination-of-cardiac-death lung transplant collaborative. Am J Transplant (2012) 1.57
A double-blind study of the speed of onset of analgesia following intramuscular administration of ketorolac tromethamine in comparison to intramuscular morphine and placebo. Anaesthesia (1991) 1.57
Mapping and characterization of new EST-derived microsatellites for potato (Solanum tuberosum L.). Theor Appl Genet (2005) 1.54
An automated communication system in a contact registry for persons with rare diseases: scalable tools for identifying and recruiting clinical research participants. Contemp Clin Trials (2008) 1.52
Factors associated with the development of Pneumocystis carinii pneumonia in 5,025 European patients with AIDS. AIDS in Europe Study Group. Clin Infect Dis (1995) 1.51
Non-Acanthamoeba amebic keratitis. Cornea (1998) 1.51
Parents' knowledge of neonatal screening and response to false-positive cystic fibrosis testing. J Dev Behav Pediatr (1992) 1.47
Ranitidine--a new H2-receptor antagonist. Gut (1980) 1.47
Use of the Alcohol Use Disorders Identification Test (AUDIT) to determine the prevalence of alcohol misuse among HIV-infected individuals. Int J STD AIDS (2013) 1.46
Timing of surgery for fulminating pseudomembranous colitis. Br J Surg (1998) 1.45
Porphyrin abnormalities in acquired immunodeficiency syndrome. Arch Dermatol (1996) 1.44
Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics. Biochem J (1992) 1.44
Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors. AIDS (1999) 1.44
The effect of various drugs on the glucuronidation of zidovudine (azidothymidine; AZT) by human liver microsomes. Br J Clin Pharmacol (1991) 1.42
The effect of zidovudine dose on the formation of intracellular phosphorylated metabolites. AIDS (1996) 1.41
The great pretender returns to Dublin, Ireland. Sex Transm Infect (2001) 1.40
The interaction of antibiotics with synthetic steroids in the rat [proceedings]. Br J Pharmacol (1978) 1.40
Improvement of platelet counts in steroid-unresponsive idiopathic immune thrombocytopenic purpura after short-course therapy with recombinant alpha 2b interferon. Blood (1989) 1.39
Selective serotonin reuptake inhibitors in children and adolescents. S Afr Med J (2006) 1.38
Online information on AIDS. J R Coll Gen Pract (1988) 1.38
Lamivudine (3TC) phosphorylation and drug interactions in vitro. Biochem Pharmacol (1997) 1.37
Interindividual variation and drug interactions with hormonal steroid contraceptives. Drugs (1981) 1.36
All day drinking--its impact on an accident and emergency department. Health Trends (1990) 1.36
The intracellular pharmacology of antiretroviral protease inhibitors. J Antimicrob Chemother (2004) 1.35
P-Glycoprotein and transporter MRP1 reduce HIV protease inhibitor uptake in CD4 cells: potential for accelerated viral drug resistance? AIDS (2001) 1.35
Factors associated with prolonged symptoms and severe disease due to Clostridium difficile. Age Ageing (1999) 1.31
Community-acquired Clostridium difficile infection. J Infect (1998) 1.30
Laparoscopic pyloromyotomy: a safer technique. Pediatr Surg Int (1998) 1.30
Evaluating symptoms in chronic obstructive pulmonary disease: validation of the Breathlessness, Cough and Sputum Scale. Respir Med (2003) 1.25
Zidovudine phosphorylation in HIV-infected patients and seronegative volunteers. AIDS (1994) 1.25
Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes. Br J Clin Pharmacol (1998) 1.25
Current concepts of the management of dental extractions for patients taking warfarin. Aust Dent J (2003) 1.24
Stability of buffered lidocaine and epinephrine used for local anesthesia. J Dermatol Surg Oncol (1991) 1.22
p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears. J Clin Pathol (2003) 1.22
Comparative trials of live attenuated and detergent split influenza virus vaccines. J Hyg (Lond) (1975) 1.22
Interaction of sildenafil and indinavir when co-administered to HIV-positive patients. AIDS (1999) 1.21
Emergency department use and misuse. J Emerg Med (1995) 1.20
St Johns wort increases expression of P-glycoprotein: implications for drug interactions. Br J Clin Pharmacol (2002) 1.18
Therapeutic drug monitoring as a tool in treating HIV infection. AIDS (2001) 1.18
Prospective randomised open-label comparison of danaparoid with dextran 70 in the treatment of heparin-induced thrombocytopaenia with thrombosis: a clinical outcome study. Thromb Haemost (2001) 1.17
Children's estimates of food portion size: the development and evaluation of three portion size assessment tools for use with children. Br J Nutr (2007) 1.16
The interaction of phenytoin and carbamazepine with combined oral contraceptive steroids. Br J Clin Pharmacol (1990) 1.16
Evaluation of liquid-based cytology in cervical screening of high-risk populations: a split study of colposcopy and genito-urinary medicine populations. Cytopathology (2002) 1.16
The pharmacokinetics of methadone in HIV-positive patients receiving the non-nucleoside reverse transcriptase inhibitor efavirenz. Br J Clin Pharmacol (2001) 1.16
The removal of 14 C-edrophonium from the circulation. Br J Pharmacol (1972) 1.16
Differences in the intracellular accumulation of HIV protease inhibitors in vitro and the effect of active transport. AIDS (2001) 1.15
The role of therapeutic drug monitoring in treatment of HIV infection. Br J Clin Pharmacol (2001) 1.14
Antiretroviral drug concentrations in semen of HIV-infected men: differential penetration of indinavir, ritonavir and saquinavir. J Antimicrob Chemother (2001) 1.14
Sequelae and support after termination of pregnancy for fetal malformation. Br Med J (Clin Res Ed) (1985) 1.14
Effect of chloroquine and primaquine on antipyrine metabolism. Br J Clin Pharmacol (1983) 1.13
The natural history of beryllium sensitization and chronic beryllium disease. Environ Health Perspect (1996) 1.12
NFAT regulates induction of COX-2 and apoptosis of keratinocytes in response to ultraviolet radiation exposure. FASEB J (2008) 1.12
Chondroid metaplasia in a fibroepithelial polyp of the tongue. J Laryngol Otol (2001) 1.12
Pharmacokinetic interactions of nevirapine and methadone and guidelines for use of nevirapine to treat injection drug users. Clin Infect Dis (2001) 1.12
Sulphation and glucuronidation of ethinyloestradiol in human liver in vitro. J Steroid Biochem (1988) 1.12
Measurement and determinants of the natural history of liver fibrosis in hepatitis C virus infection: a cross sectional and longitudinal study. Gut (2003) 1.11
The molecular epidemiology of human immunodeficiency virus type 1 in six cities in Britain and Ireland. Virology (1997) 1.11
Pharmacokinetics of mefloquine alone or in combination with artesunate. Bull World Health Organ (1994) 1.11